GT Biopharma Inc. (GTBP) PT Lowered to $5 at H.C. Wainwright
Tweet
Share
E-mailGet Alerts GTBP Hot Sheet
Price: $0.30 -3.23%
Rating Summary:
3 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 7 | New: 3
Rating Summary:
3 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 7 | New: 3
Join SI Premium – FREE
H.C. Wainwright analyst Robert Burns lowered the price target on GT Biopharma Inc. (NASDAQ: GTBP) to $5.00 (from $25.00) while maintaining a Buy rating.
You May Also Be Interested In
- Berenberg Downgrades Lanxess AG (LXS:GR) (LNXSF) to Sell
- Aryzta AG (ARYN:SW) (ARZTY) PT Lowered to CHF70 at Berenberg
- ISS A/S (ISS:DC) (ISFFF) PT Raised to DKK340 at Berenberg
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
